share_log

Intensity Therapeutics Signs Collaboration Agreement With The Swiss Group For Clinical Cancer Research SAKK To Conduct Phase 2 Breast Cancer Trial In Europe For INT230-6

Intensity Therapeutics Signs Collaboration Agreement With The Swiss Group For Clinical Cancer Research SAKK To Conduct Phase 2 Breast Cancer Trial In Europe For INT230-6

Intensity Therapeutics 与瑞士临床癌症研究集团签署合作协议 SAKK 将在欧洲进行 INT230-6 的二期乳腺癌试验
Benzinga ·  05/10 20:04

Intensity Therapeutics Signs Collaboration Agreement With The Swiss Group For Clinical Cancer Research SAKK To Conduct Phase 2 Breast Cancer Trial In Europe For INT230-6

Intensity Therapeutics 与瑞士临床癌症研究集团签署合作协议 SAKK 将在欧洲进行 INT230-6 的二期乳腺癌试验

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发